Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up in a single-center cohort study

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation?

(2017) E.J. Smolders et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C

(2017) Inmaculada Fernández et al.   JOURNAL OF HEPATOLOGY

Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral Agents

(2017) Michelle Lubetzky et al.   TRANSPLANTATION

Immune Reconstitution After HCV Clearance With Direct Antiviral Agents

(2017) Jens M. Werner et al.   TRANSPLANTATION

Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents

(2016) D. Sawinski et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Safety and efficacy of elbasvir and grazoprevir for treatment of hepatitis C

(2016) Andres F. Carrion et al.   Expert Opinion On Drug Safety

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

(2016) Fabio Conti et al.   JOURNAL OF HEPATOLOGY

Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients

(2016) Lionel Rostaing et al.   TRANSPLANT INTERNATIONAL

DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting

(2016) Sandra Beinhardt et al.   TRANSPLANT INTERNATIONAL

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

(2016) Ming V. Lin et al.   PLoS One

Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation

(2015) N. Kamar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

(2015) Christoph Höner zu Siederdissen et al.   CLINICAL INFECTIOUS DISEASES

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

(2015) Michael P. Curry et al.   GASTROENTEROLOGY

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

(2015) Xavier Forns et al.   HEPATOLOGY

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

(2015) Marc Bourlière et al.   LANCET INFECTIOUS DISEASES

Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation

(2015) Yoshihide Ueda et al.   TRANSPLANT INTERNATIONAL

Sofosbuvir in the Treatment of Chronic Hepatitis C: New Dog, New Tricks

(2014) G. M. Abraham et al.   CLINICAL INFECTIOUS DISEASES

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

(2014) Paul Y. Kwo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation

(2014) Mario Fernández-Ruiz et al.   TRANSPLANT INTERNATIONAL

Hepatitis C virus NS5A inhibitors and drug resistance mutations

(2014) Shingo Nakamoto   WORLD JOURNAL OF GASTROENTEROLOGY

Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate

(2013) P. N. Morcos et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Sofosbuvir (GS-7977), a pan-genotype, direct-acting antiviral for hepatitis C virus infection

(2013) Maribel Rodríguez-Torres   Expert Review of Anti-Infective Therapy

Meta-analysis of observational studies: hepatitis C and survival after renal transplant

(2013) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C and renal transplantation

(2012) Jose M. Morales et al.   Current Opinion in Organ Transplantation

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients

(2012) Stefania Paolucci et al.   Virology Journal

Impact of Hepatitis C Virus Infection on the Risk of Infectious Complications After Kidney Transplantation: Data From the RESITRA/REIPI Cohort

(2011) Francisco López-Medrano et al.   TRANSPLANTATION

Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons

(2008) Laura Dickinson et al.   Current Opinion in HIV and AIDS